-
Unveiling the Hidden Risks: An Update Decade-Long Analysis of Abraxane-Related Adverse Events from the FAERS Database
14 Nov 2024 09:57 GMT
… cell lung cancer, and pancreatic carcinoma.6–8
Abraxane was … the analysis specifically targeted Abraxane-related effects.
Results … understand their association with Abraxane. Overall, these … -squamous non-small-cell lung cancer (IMpower130): a multicentre, …
-
Chinese generic drug for breast, pancreatic, and lung cancer approved in EU market
31 Jul 2024 22:56 GMT
… ;s and Celgene's Abraxane®(Nab-paclitaxel). Apexelsin® is developed … cancer and non-small cell lung cancer (NSCLC), as well as a …
-
FDA Grants Fast Track Designation to IMM-1-104 for Advanced Melanoma
13 Dec 2024 11:10 GMT
… RAS-mutant non-small cell lung cancer (NSCLC). In some study arms … modified gemcitabine and nab-paclitaxel (Abraxane; Bristol Myers Squibb), or in …
-
Clinical Trials for Oral, Inhaled and Intravenous Drug Delivery System for Lung Cancer and Emerging Nanomedicine-Based Approaches
21 Dec 2023 04:45 GMT
… lung cancers. The two broad histological subtypes of lung cancer are small cell lung cancer … specifically accumulate in lung tumor tissues, improving drug … targeted delivery to lung tumors is a promising … .
One example is Abraxane (nab-paclitaxel). When …
-
FDA approves new Bristol Myers drug for lung cancer
16 Nov 2023 21:00 GMT
… Myers Squibb’s new lung cancer medication Augtyro, which the … with non-small cell lung cancer have this alteration, and … Opdivo transformed the treatment of lung cancer. But for patients with … lived products like Revlimid, Abraxane and Eliquis hit or approach …
-
Cardiff Oncology Announces Positive Clinical Data in Pancreatic Cancer and Small Cell Lung Cancer, including Single-Agent Activity from Onvansertib Monotherapy
27 Sep 2023 03:17 GMT
… SoC -
Small Cell Lung Cancer Program
- Preliminary data from … onvansertib with SoC (Gemzar + Abraxane). In cohort 2, patients … initiated trials in small cell lung cancer (SCLC) and triple … -cancer-and-small-cell-lung-cancer-including-single-agent-activity- …
-
GNPNAT1 Predicts Poor Prognosis and Cancer Development in Non-Small Cell Lung Cancer
10 Aug 2022 20:52 GMT
… of lung cancers are classified as non-small cell lung cancer (NSCLC … Abraxane resulted in significant downregulation of GNPNAT1 in lung cancer … Metastatic Ability of Lung Cancer Cells
GNPNAT1 mRNA … detected its function in lung cancer cells, and consequently …
-
Research Progress on Cyclic-Peptide Functionalized Nanoparticles for Tumor-Penetrating Delivery
26 Nov 2024 12:17 GMT
… iRGD-targeted Abraxane compared to non-targeted Abraxane, highlighting … cancer, pancreatic cancer, and lung cancer, underscoring their potential utility … . Furthermore, LyP-1-abraxane displayed a markedly higher … in non-small cell lung cancer. J Hematol Oncol. …
-
Multifunctional Indomethacin Conjugates for the Development of Nanosystems Targeting Cancer Treatment
26 Nov 2024 12:17 GMT
… , many nanoformulations such as Doxil®, Abraxane®, DepoCyt®, Genexol®-PM, and AmBisome … , Virginia, USA).Human non-small lung cancer A-549, prostate cancer PC …
-
One Sector Has Underperformed Massively: These 4 Blue-Chip Dividend Giants Are Huge 2025 Plays
25 Nov 2024 17:08 GMT
… with unresectable or metastatic melanoma
Abraxane, a protein-bound chemotherapy product … as prostate cancer, hematologic malignancies, lung cancer, and bladder cancer
Cardiovascular and …
About
© 1995-2024